Thermostable Formulation Could Free mRNA Vaccines from the Cold Chain
Sep 28, 2026
MIT researchers used AI to develop thermostable mRNA vaccine formulations that retained bioactivity at high temperatures and could enable vaccine delivery through dissolvable microneedle patches.
Read More –Proliferative Pause Reveals Window to Prevent Brain Metastasis
Sep 28, 2026Just a Flesh Wound: The Combative Quest for Cancer’s Holy Grail
Sep 25, 2026Detecting Ovarian Cancer Earlier with New MIT Tissue Sampling Device
Sep 24, 2026Off Script: Why Some CAR T Patients Develop Enterocolitis—and How to Treat It
Sep 23, 2026New Immunotherapy Strategy Extends KRAS Inhibitor Response in Pancreatic Cancer
Sep 23, 2026Breast Cancer-Linked Chemicals Widespread in U.S. Consumer Products
Sep 23, 2026Twenty Seconds of Speech May Help Spot Diabetes
Sep 29, 2026
Heart and Kidney Problems in Type 2 Diabetes Patients Increase with Time
Sep 26, 2026
Blood Test Differentiates Bacterial and Viral Infections in Newborns
Sep 26, 2026
Alzheimer’s Drug Effects Revealed with Plasma Biomarker Changes
Sep 25, 2026
Riaan’s Therapeutic Odyssey – Chapter 4: The Drug Developers
Sep 24, 2026
Engineers Use the Body as a Network to Connect Wearable and Implantable Devices
Sep 24, 2026
News & Features
Gene-Edited CAR T Expands Rare Disease Horizons
August 01, 2026Combining CAR T with CRISPR or TALEN is enabling more precise, scalable cell therapies for autoimmune, fibrotic, and genetic disorders.
From Mila to Many: Making Ultra-Rare Disease Therapies More Accessible
August 01, 2026Newer options like the therapies being developed by Forster and colleagues at Nerai Biosciences, alongside others like potentially curative gene therapies, are on the horizon…
Drug Repurposing’s Next Challenge: Turning Discoveries Into Treatments
August 01, 2026The U.S. Food and Drug Administration (FDA) is now actively involving patients, researchers, and clinicians in efforts to prioritize drug repurposing in areas where commercial…
Highly Multiplexed Droplet Digital PCR for Ultra-Sensitive NSCLC Biomarker Detection in Research Workflows
In this IPM webinar, two experts will discuss the growing role of ddPCR in clinical research and translational oncology.
Surbhi Jain, PhD, MBBS
Staff Scientist
Bio-Rad Laboratories
Prithwish Pal, PhD
Director, Global Product Marketing – Oncology
Bio-Rad Laboratories
Signatera Surges in Liquid Biopsy Race with New Lung Cancer Data and a Japan Approval
Sep 23, 2026On Tuesday, Natera announced its Signatera test was approved by Japan’s Pharmaceuticals and Medical Devices Agency as a companion diagnostic in muscle-invasive bladder cancer to…
Inherited EGFR Mutation Raises Lung Cancer Risk in Nonsmokers
Sep 23, 2026Analysis of more than 3.3 million people found that carriers of inherited EGFR T790M, particularly nonsmokers, had substantially increased lung cancer risk compared with non-carriers.
Wei-Wu He: Craig Venter’s Legacy and the Future of Human Longevity
Sep 23, 2026Human Longevity's executive chairman discusses Craig Venter's long-term goal of using genomics and AI to extend healthy life and dramatically reduce serious illness.
Podcast Series
Behind the Breakthroughs
Join host Jonathan D. Grinstein, PhD, North American Editor for Inside Precision Medicine, as he uncovers the stories behind the pioneers driving the precision medicine revolution.
Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter.
